
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            First-in-Human Safety, Tolerability, Efficacy, and Pharmacokinetics of Pegfosimer Manganese (SN132D) for Contrast-Enhanced MRI of Breast Cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D711E389B716831C11E30021BD93FB.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="lwwopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12316140/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Investigative Radiology">
<meta name="citation_title" content="First-in-Human Safety, Tolerability, Efficacy, and Pharmacokinetics of Pegfosimer Manganese (SN132D) for Contrast-Enhanced MRI of Breast Cancer">
<meta name="citation_author" content="Fredrik Wärnberg">
<meta name="citation_author_institution" content="Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)">
<meta name="citation_author" content="Oskar Axelsson">
<meta name="citation_author_institution" content="Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)">
<meta name="citation_author" content="Dan Curiac">
<meta name="citation_author_institution" content="Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)">
<meta name="citation_author" content="Paul Hargreaves">
<meta name="citation_author_institution" content="Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)">
<meta name="citation_author" content="Andreas Karakatsanis">
<meta name="citation_author_institution" content="Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)">
<meta name="citation_author" content="Sujinna Lekmeechai">
<meta name="citation_author_institution" content="Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)">
<meta name="citation_author" content="Mats Hansen">
<meta name="citation_author_institution" content="Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)">
<meta name="citation_publication_date" content="2025 Feb 14">
<meta name="citation_volume" content="60">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="577">
<meta name="citation_doi" content="10.1097/RLI.0000000000001164">
<meta name="citation_pmid" content="39946211">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12316140/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12316140/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12316140/pdf/rli-60-577.pdf">
<meta name="description" content="The primary objective of the first-in-human (FIH) study was to evaluate the safety and tolerability of the manganese (Mn)-based contrast agent pegfosimer manganese in participants with newly diagnosed breast cancer, and secondary objectives included ...">
<meta name="og:title" content="First-in-Human Safety, Tolerability, Efficacy, and Pharmacokinetics of Pegfosimer Manganese (SN132D) for Contrast-Enhanced MRI of Breast Cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The primary objective of the first-in-human (FIH) study was to evaluate the safety and tolerability of the manganese (Mn)-based contrast agent pegfosimer manganese in participants with newly diagnosed breast cancer, and secondary objectives included ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12316140/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12316140">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1097/RLI.0000000000001164"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/rli-60-577.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12316140%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12316140/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12316140/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12316140/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-lwwopen.png" alt="Lippincott Open Access logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Lippincott Open Access" title="Link to Lippincott Open Access" shape="default" href="https://doi.org/10.1097/RLI.0000000000001164" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Invest Radiol</button></div>. 2025 Feb 14;60(9):577–585. doi: <a href="https://doi.org/10.1097/RLI.0000000000001164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1097/RLI.0000000000001164</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Invest%20Radiol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Invest%20Radiol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Invest%20Radiol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Invest%20Radiol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>First-in-Human Safety, Tolerability, Efficacy, and Pharmacokinetics of Pegfosimer Manganese (SN132D) for Contrast-Enhanced MRI of Breast Cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22W%C3%A4rnberg%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Fredrik Wärnberg</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Fredrik Wärnberg</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>1</sup>Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22W%C3%A4rnberg%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fredrik Wärnberg</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Axelsson%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Oskar Axelsson</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Oskar Axelsson</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>1</sup>Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Axelsson%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Oskar Axelsson</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Curiac%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Dan Curiac</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Dan Curiac</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>1</sup>Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Curiac%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dan Curiac</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hargreaves%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Paul Hargreaves</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Paul Hargreaves</span>, <span class="degrees">MSc</span>
</h3>
<div class="p">
<sup>1</sup>Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hargreaves%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paul Hargreaves</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karakatsanis%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Andreas Karakatsanis</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">Andreas Karakatsanis</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>1</sup>Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Karakatsanis%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andreas Karakatsanis</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lekmeechai%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Sujinna Lekmeechai</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Sujinna Lekmeechai</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>1</sup>Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lekmeechai%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sujinna Lekmeechai</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hansen%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Mats Hansen</span></a><div hidden="hidden" id="id7">
<h3>
<span class="name western">Mats Hansen</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>1</sup>Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hansen%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mats Hansen</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden (F.W.); Spago Nanomedical AB, Lund, Sweden (O.A., P.H., S.L., M.H.); CTC Gothia Forum, Sahlgrenska University Hospital, Göteborg, Sweden (D.C.); and Uppsala Universitet, Institutionen för Kirurgiska Vetenskaper, Endokrinkirurgi, Uppsala, Sweden (A.K.)</div>
<div class="author-notes p"><div class="fn" id="corresp1">
<sup>✉</sup><p class="display-inline">Correspondence to: Mats Hansen, PhD, Spago Nanomedical AB, Scheelevägen 22, SE-223 63 Lund, Sweden. E-mail: <span>mats.hansen@spagonanomedical.se</span>.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Oct 16; Accepted 2025 Jan 11; Collection date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)</a>, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12316140  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39946211/" class="usa-link">39946211</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Objectives:</h3>
<p>The primary objective of the first-in-human (FIH) study was to evaluate the safety and tolerability of the manganese (Mn)-based contrast agent pegfosimer manganese in participants with newly diagnosed breast cancer, and secondary objectives included preliminary efficacy, and pharmacokinetics (PK) of the agent.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods:</h3>
<p>A single intravenous 1-hour infusion of pegfosimer manganese was administered to 2 cohorts; 6 participants at the starting dose of 10 μmol Mn/kg, followed by 8 participants at the expansion dose of 20 μmol Mn/kg, cohorts 1 and 2, respectively. The safety was evaluated based on reported adverse events (AEs), including serious AEs, physical examination, vital signs, electrocardiogram, and safety laboratory parameters. Magnetic resonance imaging (MRI) acquisition was performed precontrast and postcontrast to assess the clinical relevance of images in primary breast tumors, liver, and pancreas relative to reference tissue. PK parameters were calculated from a noncompartmental analysis of the plasma Mn concentrations versus time.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results:</h3>
<p>There was a total of 29 AEs reported to all participants of the 2 cohorts. The AEs were mostly of mild to moderate severity and possibly or probably related to the contrast agent. No clinically significant changes in the safety laboratory parameters were reported, except for transiently elevated transaminases observed at the end of the infusion. Clinically relevant low-background MRI scans for clinical visualization of primary breast tumor, liver, and pancreas were obtained at the expanded dose level. Pegfosimer manganese has an initial plasma half-life of approximately 7 minutes.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion:</h3>
<p>The FIH study of pegfosimer manganese demonstrated an acceptable safety profile and sufficient contrast enhancement for clinically relevant MRI sequences in participants with primary breast tumors.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Key Words:</strong> contrast agent, MRI, breast cancer, phase 1, tumor, liver, pancreas, manganese</p></section></section><hr class="headless">
<p>Breast cancer is the most common malignant disease occurring in women worldwide, accounting for an incidence of 31% of all female cancers 2023.<a href="#bib1" class="usa-link" aria-describedby="bib1">1</a> Early detection and correct diagnosis of breast cancer are prerequisites for optimized treatment selection and successful outcomes. Mammography and ultrasound are the most commonly used imaging tools for the detection and characterization of breast abnormalities; however, the relatively low sensitivity and specificity of these techniques, especially in patients with dense breast tissue,<a href="#bib2" class="usa-link" aria-describedby="bib2">2</a>,<a href="#bib3" class="usa-link" aria-describedby="bib3">3</a> has created a demand for new imaging modalities.</p>
<p>Contrast-enhanced magnetic resonance imaging (MRI) enables a high degree of soft tissue contrast, spatial resolution, and depth of penetration and provides superior sensitivity, compared with mammography and ultrasound, in the detection of breast cancer.<a href="#bib2" class="usa-link" aria-describedby="bib2">2</a>,<a href="#bib3" class="usa-link" aria-describedby="bib3">3</a> However, the specificity for lesion characterization is still low to moderate, turning the discrimination between cancer and benign lesions into a challenge. According to a meta-analysis of ≥1.5 T MRI accuracy in breast cancer staging, the positive predictive value was 75% (95% confidence interval: 64%–83%).<a href="#bib4" class="usa-link" aria-describedby="bib4">4</a>
</p>
<p>Contrast agents used during MRI examinations in clinical practice today are small-molecule gadolinium (Gd)-based substances, which rapidly extravasate nonselectively into tissues and therefore require fast data acquisition, a process known as dynamic imaging.<a href="#bib5" class="usa-link" aria-describedby="bib5">5</a>,<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a> In general, fast data acquisition comes at the cost of spatial resolution, which contributes to reduced specificity and a number of false-positive findings of tumor lesions. False-positive findings may lead to anxiety and suffering for the individual, in addition to increased costs for subsequent unnecessary examinations.<a href="#bib7" class="usa-link" aria-describedby="bib7">7</a> Thus, there is a clear clinical and socioeconomic need for improved cancer diagnostic tools.<a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>
</p>
<p>The investigational product pegfosimer manganese (SN132D) is a low-molecular-weight macromolecular contrast agent (average diameter 5.6 nm, 45 kDa) for MRI developed by Spago Nanomedical AB. The T1-weighted longitudinal relaxivity of pegfosimer manganese has previously been established in vitro as approximately 30 mM<sup>−1</sup> s<sup>−1</sup> in human serum at 37°C and 1.5 T; this would be higher than contrast agents in clinical use today.<a href="#bib9" class="usa-link" aria-describedby="bib9">9</a>
</p>
<p>Pegfosimer manganese utilizes the physiological phenomenon known as the enhanced permeability and retention (EPR) effect. The tumor angiogenesis provides an environment driving vascular growth in an uncontrolled manner resulting in immature, rigid, and hyperpermeable vasculature.<a href="#bib10" class="usa-link" aria-describedby="bib10">10</a> This effect allows for molecules with a diameter of a few nm to 100 nm to permeate tumor tissue.<a href="#bib11" class="usa-link" aria-describedby="bib11">11</a> Utilizing the EPR effect will allow a nanosized molecule to preferentially accumulate in malignant tissue.</p>
<p>The 5 unpaired electrons in the manganese (Mn)-ions chelated to pegfosimer manganese provide suitable properties for MRI enhancement. By interacting with water protons, the Mn-ions will shorten the T1-weighted relaxivity, and to some extent also the T2-weighted relaxivity, resulting in a local signal increase.<a href="#bib12" class="usa-link" aria-describedby="bib12">12</a> The gradual build-up of signal caused by the accumulation in malignant tissue of contrast agent and the subsequent slow washout enables an extended time window for imaging of up to several hours; this allows for high spatial resolution images and flexibility in the workflow for the MRI site.</p>
<p>Results from this first-in-human (FIH) study demonstrate an acceptable safety profile for pegfosimer manganese at doses of 10 and 20 μmol Mn/kg and sufficient contrast enhancement to acquire clinically relevant MRI sequences at the latter dose.</p>
<section id="sec5"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="sec6"><h3 class="pmc_sec_title">Study Population</h3>
<p>The FIH phase I study was designed as an open-label, nonrandomized, non–placebo-controlled study of the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of the contrast agent pegfosimer manganese in newly diagnosed breast cancer patients. The study was conducted at Sahlgrenska University Hospital, Gothenburg, Sweden, and Uppsala Academic Hospital, Uppsala, Sweden, from September 2019 to November 2022 (<a href="https://clinicaltrials.gov/ct2/show/NCT04080024" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT04080024</a>). A written informed consent was obtained from each study participant before any study protocol activities took place. The trial was approved by the Swedish Independent Ethics Committee and conducted following Good Clinical Practice (GCP) guidelines of the International Conference on Harmonization and the 2013 World Medical Association Declaration of Helsinki<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a> and subsequent updates.</p>
<p>Female patients at least 18 years of age with histological or cytological diagnosis of breast cancer (tumor &gt;5 mm; cT1c-cT4; cN0-cN3; Mx) and signed informed consent were considered eligible to participate in the study. In total, 16 female breast cancer patients were included, and 14 of those fulfilled the inclusion/exclusion criteria for participation in the study. Histologically or cytologically confirmed breast cancer patients, aged 18 or above, exhibiting an Eastern Cooperative Oncology Group<a href="#bib14" class="usa-link" aria-describedby="bib14">14</a> performance status of maximum 1, adequate renal and hepatic function at screening, who were willing to undertake 3 preoperative MRI investigations in 1 day were eligible to participate in the study. Patients who had any condition that was contraindicated with the MRI examination, including but not limited to body mass index (BMI) &gt;40 kg/m<sup>2</sup>, claustrophobia, history of brain or heart surgery, metallic implant (eg, pacemaker, cochlear implant), permanent make-up, work as metalworkers or welders, or inability to stay in prone position for 45 minutes, were excluded from the study.</p></section><section id="sec7"><h3 class="pmc_sec_title">Study Design and Study Drug Administration</h3>
<p>Pegfosimer manganese (supplied as a 65-mM Mn sterile solution manufactured by Basic Pharma Manufacturing PV, Geleen, the Netherlands) was thawed overnight in a refrigerator and brought to room temperature at least 1 hour before the administration of 10, or 20 μmol Mn/kg, given as a single intravenous infusion over 1 hour at a rate of 5 mL/h, in combination with a saline carrier. The total administered volume varied based on the body weight. As a precaution for acute hypersensitivity reactions related to the infusion, pegfosimer manganese was administered using a slow intravenous infusion for 1 hour. To warrant any potential infusion-related reactions in response to the polyethylene glycol–coating of pegfosimer manganese and toxicity-related reactions from Mn, the protocol allowed for enough time to detect potential acute and long-term toxicities; the first 3 participants in each cohort were dosed at least 1 week apart, and the remaining participants were at least 24 hours apart.</p>
<p>The study was designed as a dose escalation study of 3 dose levels (10, 20, and 30 μmol Mn/kg) administered to 3 sequential cohorts, allowing for improvement of MRI quality. The formal stopping rule for dose escalation (Table <a href="#T1" class="usa-link">1</a>) was strictly followed as per the Common Terminology Criteria for Adverse Events (CTCAE) v5.0,<a href="#bib15" class="usa-link" aria-describedby="bib15">15</a> considering the recommendations published by Sibille et al,<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a> an adaptation to FIH studies of the grading system proposed by the World Health Organization,<a href="#bib17" class="usa-link" aria-describedby="bib17">17</a> National Institutes of Health,<a href="#bib18" class="usa-link" aria-describedby="bib18">18</a> and Food and Drug Administration.<a href="#bib19" class="usa-link" aria-describedby="bib19">19</a> To proceed with any dose escalations, the safety, PK, and MRI scan quality was reviewed by an independent safety review committee (iSRC).</p>
<section class="tw xbox font-sm" id="T1"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Applied Dose Escalation Stopping Rules</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr valign="top">
<th align="left" axis="1" rowspan="1" colspan="1">Level</th>
<th align="center" axis="1" rowspan="1" colspan="1">Actions Taken</th>
</tr></thead>
<tbody>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">If no participants have a SADR, ie, an SAE considered at least possibly related to the pegfosimer manganese administration</td>
<td align="left" rowspan="1" colspan="1">1. Escalate to the next higher dose level.</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">If 1 participant has a SADR</td>
<td align="left" rowspan="1" colspan="1">1. Stop further dosing at the current dose level.2. Evaluation by iSRC. The iSRC makes recommendation to sponsor.3. Sponsor decides if dosing should commence at a previous lower  dose level or at an intermediate dose level.</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">If 2 participants have a severe, nonserious adverse reaction considered at least possibly related to the pegfosimer manganese administration (independent of within/not within the same SOC).</td>
<td align="left" rowspan="1" colspan="1">1. Stop further dosing at the current dose level.2. Evaluation by iSRC. The iSRC makes recommendation to sponsor.3. Sponsor decides if dosing should commence at the previous lower  dose level or at an intermediate dose level.</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">If 1 out of 3, or 2 out of 6, participants have to delay their planned breast surgery due to AEs deemed at least possibly related to the pegfosimer manganese administration.</td>
<td align="left" rowspan="1" colspan="1">1. Stop further dosing at the current dose level.2. Evaluation by iSRC. The iSRC makes recommendation to sponsor.3. Sponsor decides if dosing should commence at the previous lower  dose level or at an intermediate dose level.</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">At least 1 participant has a plasma C<sub>max</sub> higher than 47.9 μg Mn/mL, or an AUC higher than 72 mM Mn × min</td>
<td align="left" rowspan="1" colspan="1">1. Stop further dosing at the current dose level.2. Evaluation by iSRC. The iSRC makes recommendation to sponsor.3. Sponsor decides if dosing should commence at the previous lower  dose level or at an intermediate dose level.</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">If 2 participants have a SADR</td>
<td align="left" rowspan="1" colspan="1">1. Stop further dosing.2. Termination of study.</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn1"><p>AEs indicates adverse events; AUC, area under the curve; C<sub>max</sub>, maximum plasma concentration; iSRC, independent safety review committee, Mn, manganese; SADR, serious adverse drug reaction; SAE, serious adverse event; SOC, system organ class.</p></div></div></section><p>The study duration for each participant was approximately 24 to 30 days, including a 10-day screening period and an approximate 2- to 3-week follow-up period. Participants attended at least 3 visits related to the clinical study. At screening, demographics, physical examination, prior and concomitant medications, and eligibility were recorded. Screening took place within 10 days of the planned dosing day. On the day of dosing, eligible participants were admitted to the FIH unit for assessment of baseline parameters, including a baseline unenhanced MRI scan to determine baseline signals in target tissues, following study drug administration as a single intravenous infusion over 1 hour together with a saline carrier. Postdose MRI scans were performed on 2 separate occasions, 1 or 2 hours and 4 hours after the end of the infusion, respectively. After the infusion, the participants were observed at the FIH unit for up to 25 hours with regular registration of safety and PK blood samplings, see below. The visit for safety follow-up evaluation was scheduled 14 days from the day of study drug administration.</p></section><section id="sec8"><h3 class="pmc_sec_title">Safety Assessment</h3>
<p>The overall safety, including AEs and serious AEs (SAEs), was assessed from the start of the pegfosimer manganese single intravenous infusion until the end-of-study visit by medical clinicians. The grading of the severity/intensity (grade 1 to grade 5) of AEs followed the CTCAE v5.0.<a href="#bib15" class="usa-link" aria-describedby="bib15">15</a> AEs were assessed as unlikely, possibly, or probably related to the study drug. Injection site reactions (redness, itching, pain, swelling, bruising, burning) were reported as AEs. A single 12-lead electrocardiogram (ECG) was recorded in a supine position after 10 minutes of rest using an ECG machine predosing, 30 minutes, 1 hour, 2 hours, 4 hours, 7 hours, and 9 hours postdosing start, and at the safety follow-up visit to assess heart rate, PQ/PR, QRS, QT, and QTcF intervals. All ECG values were reviewed and interpreted on site by the investigator. A complete physical examination included assessments of the head, eyes, ears, nose, throat, skin, thyroid, neurological, lungs, cardiovascular, abdomen, lymph nodes, and extremities and was conducted predosing, and 9 hours postdosing. Vital signs, comprising, systolic and diastolic blood pressure, pulse, respiratory rate, saturation, and body temperature were measured in a supine position after 5 minutes of rest predosing, 30 minutes, 1 hour, 2 hours, 4 hours, 7 hours, 9 hours postdosing start, and at the safety follow-up visit. Blood samples for analysis of clinical chemistry and hematology parameters were collected predosing, 9 hours postdosing start, and at the safety follow-up visit through venipuncture or a peripheral venous catheter.</p></section><section id="sec9"><h3 class="pmc_sec_title">Pharmacokinetic Analysis</h3>
<p>Plasma concentrations of Mn were determined by sampling approximately 5 mL venous blood, collected through a peripheral venous catheter of the study drug at the following time points postdosing start; 60 minutes before (baseline), 0 minutes, 10 minutes, 20 minutes, 60 minutes, 65 minutes, 75 minutes, 90 minutes, 105 minutes, 2 hours, 3 hours, 5 hours, 9 hours postdosing start, and lastly 1 sample between day 3 to day 14. The time point of PK sampling did not deviate more than ±10% from the planned time. The blood samples were collected in prelabeled lithium heparin tubes. The collected blood samples were kept at approximately 4°C and were, within 1 hour, centrifuged in a refrigerated centrifuge at 1800<em>g</em> for 10 minutes to separate the plasma and frozen at −20°C.</p>
<p>Analysis was based on the actual sampling times recorded during the study. To calculate PK parameters, concentrations below the lower limit of quantification (LLOQ) occurring before C<sub>max</sub> was defined as zero. Concentrations below LLOQ occurring after C<sub>max</sub> were omitted from the analysis. C<sub>max</sub>, T<sub>max</sub>, and T<sub>last</sub> were derived from the observed plasma concentration data. AUC was derived by integration of the plasma concentration versus time curve using linear interpolation for increasing plasma levels and logarithmic interpolation for decreasing plasma levels (linear up-log down method). AUC<sub>0-t</sub> was calculated from time 0 to the time t of the last detectable plasma concentration. For AUC<sub>0-inf</sub>, the area was calculated to the last time point with a measurable plasma concentration and then extrapolated to infinity using the concentration in the last quantifiable sample and lambda<sub>z</sub>. The plasma elimination half-life (T<sub>½z</sub>) was calculated by ln 2/lambda<sub>z</sub>. The initial plasma half-life (T<sub>1/2initial</sub>) was estimated by linear-logarithmic regression based on the observed concentration at the end of infusion and the observed concentrations at 65 and 75 minutes after the end of infusion.</p></section><section id="sec10"><h3 class="pmc_sec_title">MRI Protocol</h3>
<p>The imaging protocol was optimized on both sites via test scanning at the clinical sites of phantoms, calibrated with 0.5 mmol/mL Gd Dotarem, and healthy volunteer test persons. The test scan sequences comprised THRIVE Noise from the phantom, and Survey, THRIVE, THRIVE Noise, STIR, SPAIR, DWI, MOLLI, and VFA from the test persons. Breast scanning was performed on a 1.5 T MRI Philips Achieva dStream scanner with the dedicated Philips breast-coil BREAST 7CH, or, if participants were too large to fit the scan setup, flex-coil wrapping around the participant lying flat on the scanner bed (Uppsala Academic Hospital), or a 3 T MRI Philips Ingenia scanner with the dedicated Philips breast-coil BREAST DCI 10CH (Sahlgrenska University Hospital). On each scanner, an anterior-posterior phased-array coil (Philips) was used for the field of view. The imaging settings agreed for the trial breast and abdominal MRI acquisitions were agreed to consist of the following sequences: STIR, THRIVE spoiled gradient echo, dynamic THRIVE, T1-weighted Modified Look-Locker inversion recovery (MOLLI), 2-point water Dixon.</p></section><section id="sec11"><h3 class="pmc_sec_title">MRI Acquisition</h3>
<p>Before the first MRI acquisition, the participants were prepared according to the respective clinical site's standard requirements for MRI investigations, including the removal of metal objects such as eyeglasses and jewelry. The participants were instructed to wear ear protection and to perform breath-holding during the scanning. Each participant underwent the 30-minute long MRI scan 3 times: 1 or 2 hours, and 4 hours after the end of pegfosimer manganese infusion. The MOLLI served as the T1 quantification sequence.</p></section><section id="sec12"><h3 class="pmc_sec_title">Contrast and Signal Intensity Evaluation</h3>
<p>The quantitative image analysis was performed using a validated software, Core Lab, following an imaging processing pipeline developed by the imaging CRO (Antaros Medical, Mölndal). An external qualified radiologist evaluated the pseudonymized images. The radiologist was instructed to use all available information to increase their confidence in identifying the location of the primary tumor, liver, pancreas, and metastatic lesions. This included accessing all 3 time points, but also x-ray mammography images and noncontrast/contrast MRI examinations, if available. The measurements were produced by annotating the regions of interest to obtain the signal intensity and contrast intensity. The radiologist was instructed to place the region of interest (ROI) conservatively, to avoid regions with partial volume effects from large vessels or ducts. Upon identifying a structure, the radiologist marked it with an arrow or a circle. The annotated image sequences were then transferred to Antaros Medical AB for technical quality control and quantification of enhancement in the ROI.</p>
<p>The images were individually windowed for black background and graded contrast by acquiring scans without any excitation pulses to generate images with no signal except for noise. Briefly, the resolution and spatial coverage were reduced to make acquisition times reasonable. This required those sequence to be acquired as the last scan in a dynamic series of a minimum of 2 images, an extra low-resolution signal scan was acquired to obtain a total of 3 images. The scanner type employed in the study only allowed this technique when image acceleration was turned off (geometry parameter “Uniformity” set to “Classic”). The implementation of acquiring the noise level from a scan with modified sequence settings enabled the noise to serve as a reference signal between imaging sessions. To assess the signal-to-noise ratio (SNR), the signal was determined from a scan with high resolution, whereas the noise was determined from the faster noise scan. Special consideration to the way image signal scaling factors (DICOM tag slope) employed by Philips scanners was taken. The contrast-to-noise ratio (CNR) was determined by subtracting the signal from a reference region from the analyzed tissue before dividing with the noise level of the noise scan. The chest and back muscle tissue were selected as the reference region for breast and abdominal scans, respectively. SNR and CNR were calculated as the absolute ROI contrast intensity changes from baseline (precontrast time point) versus each postcontrast time point relative to the reference tissues.</p></section><section id="sec13"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p>All statistical analyses and descriptive summaries were performed using SAS version 9.4 (SAS Institute, Cary, NC). PK parameters were calculated by noncompartmental analysis using the software Phoenix WinNonlin version 8.3 (Certara, USA). Generally, no imputation of data was performed except for concentrations under LLOQ, which were replaced with LLOQ/2 if more than 50% of the values for a given time point were above LLOQ.</p></section></section><section id="sec14"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="sec15"><h3 class="pmc_sec_title">Recruitment and Administration</h3>
<p>The study was conducted during the period between September 2019 and November 2022. The study population comprised 14 White females with breast cancer, with a mean age of 63 years and a mean BMI of 27.75 kg/m<sup>2</sup>. Six participants received 10 μmol Mn/kg (cohort 1), and 8 participants received 20 μmol Mn/kg (cohort 2) of pegfosimer manganese, respectively. The demographic and baseline characteristics are summarized in Table <a href="#T2" class="usa-link">2</a>. Overall, the data between cohorts 1 and 2 were comparable, except for a difference in the mean age (56.8 vs 67.6 years), and BMI was higher (29.6 vs 26.4 kg/m<sup>2</sup>).</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Demographics and Baseline Characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr valign="top">
<th align="left" axis="1" rowspan="1" colspan="1">Assessment</th>
<th align="center" axis="1" rowspan="1" colspan="1">Cohort 1 (10 μmol Mn/kg)</th>
<th align="center" axis="1" rowspan="1" colspan="1">Cohort 2 (20 μmol Mn/kg)</th>
<th align="center" axis="1" rowspan="1" colspan="1">Total</th>
</tr></thead>
<tbody>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Age (y)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
<td align="center" rowspan="1" colspan="1">14</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">56.8 (9.2)</td>
<td align="center" rowspan="1" colspan="1">67.6 (8.9)</td>
<td align="center" rowspan="1" colspan="1">63.0 (10.3)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">59.0 (41, 66)</td>
<td align="center" rowspan="1" colspan="1">66.5 (56, 84)</td>
<td align="center" rowspan="1" colspan="1">64.5 (41, 84)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Sex</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Female</td>
<td align="center" rowspan="1" colspan="1">6/6 (100%)</td>
<td align="center" rowspan="1" colspan="1">8/8 (100%)</td>
<td align="center" rowspan="1" colspan="1">14/14 (100%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Male</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Ethnicity</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Hispanic or Latino</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Not Hispanic or Latino</td>
<td align="center" rowspan="1" colspan="1">6/6 (100%)</td>
<td align="center" rowspan="1" colspan="1">8/8 (100%)</td>
<td align="center" rowspan="1" colspan="1">14/14 (100%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Not reported</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Unknown</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Race</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> American Indian or Alaska Native</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Asian</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Black or African American</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Native Hawaiian or Other Pacific Islander</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> White</td>
<td align="center" rowspan="1" colspan="1">6/6 (100%)</td>
<td align="center" rowspan="1" colspan="1">8/8 (100%)</td>
<td align="center" rowspan="1" colspan="1">14/14 (100%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">ECOG</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> 0</td>
<td align="center" rowspan="1" colspan="1">4/6 (67%)</td>
<td align="center" rowspan="1" colspan="1">8/8 (100%)</td>
<td align="center" rowspan="1" colspan="1">12/14 (86%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> 1</td>
<td align="center" rowspan="1" colspan="1">2/6 (33%)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">2/14 (14%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Menopausal status</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Not performed</td>
<td align="center" rowspan="1" colspan="1">1/6 (17%)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1/14 (7.1%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Postmenopausal</td>
<td align="center" rowspan="1" colspan="1">4/6 (67%)</td>
<td align="center" rowspan="1" colspan="1">6/8 (75%)</td>
<td align="center" rowspan="1" colspan="1">10/14 (71%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Premenopausal</td>
<td align="center" rowspan="1" colspan="1">1/6 (17%)</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1/14 (7.1%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Perimenopausal</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">2/8 (25%)</td>
<td align="center" rowspan="1" colspan="1">2/14 (14%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Height (cm)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
<td align="center" rowspan="1" colspan="1">14</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">166.7 (5.8)</td>
<td align="center" rowspan="1" colspan="1">164.5 (4.4)</td>
<td align="center" rowspan="1" colspan="1">165.4 (5.0)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">165.5 (159, 176)</td>
<td align="center" rowspan="1" colspan="1">164.0 (158, 170)</td>
<td align="center" rowspan="1" colspan="1">165.5 (158, 176)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Weight (kg)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
<td align="center" rowspan="1" colspan="1">14</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">82.83 (18.78)</td>
<td align="center" rowspan="1" colspan="1">71.49 (16.53)</td>
<td align="center" rowspan="1" colspan="1">76.35 (17.80)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">78.50 (65.0, 111.0)</td>
<td align="center" rowspan="1" colspan="1">74.70 (44.0, 95.7)</td>
<td align="center" rowspan="1" colspan="1">74.70 (44.0, 111.0)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
<td align="center" rowspan="1" colspan="1">14</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">29.617 (5.243)</td>
<td align="center" rowspan="1" colspan="1">26.350 (6.090)</td>
<td align="center" rowspan="1" colspan="1">27.750 (5.776)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">28.250 (24.70, 35.80)</td>
<td align="center" rowspan="1" colspan="1">26.450 (17.60, 36.90)</td>
<td align="center" rowspan="1" colspan="1">26.450 (17.60, 36.90)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Diagnosis</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Histological</td>
<td align="center" rowspan="1" colspan="1">6/6 (100%)</td>
<td align="center" rowspan="1" colspan="1">6/8 (75%)</td>
<td align="center" rowspan="1" colspan="1">12/14 (86%)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Cytological</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">2/8 (25%)</td>
<td align="center" rowspan="1" colspan="1">2/14 (14%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn2_pmc"><p>BMI indicates body mass index; ECOG, Eastern Cooperative Oncology Group; n, number of participants; SD, standard deviation.</p></div></div></section><p>Following the dosing of cohort 1 (n = 6) with 10 μmol Mn/kg pegfosimer manganese, a recommendation to escalate the dose was issued by the iSRC. The dosing of n = 4 participants in cohort 2 revealed that 20 μmol Mn/kg was sufficient to not proceed with escalation, and this cohort was expanded to a total of n = 8 participants, a number judged to be sufficient for assessment of the imaging clinical relevance.</p></section><section id="sec16"><h3 class="pmc_sec_title">Safety Evaluation</h3>
<p>Pegfosimer manganese was generally tolerated by the participants in the study as assessed by the results from AEs, ECG, vital signs, safety laboratory parameters, and physical examinations. There were no deaths, SAEs, or AEs leading to withdrawal from the study.</p>
<p>Twelve of the 14 included participants (n = 4 out of 6 in cohort 1, n = 8 out of 8 in cohort 2) reported a total of 29 AEs (Table <a href="#T3" class="usa-link">3</a>). In general, AEs were more frequently reported by participants in cohort 2. Most AEs (25 out of 29) were assessed as possibly (10 events) or probably (15 events) related to pegfosimer manganese. The AEs were assessed as mild (18 events) or moderate (10 events) in intensity, except for 1 AE of increased transaminases experienced by a participant in cohort 2, which was assessed as severe and probably related to the study drug. All AEs of moderate to severe intensity were reported by participants in this cohort.</p>
<section class="tw xbox font-sm" id="T3"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Adverse Events Classified by the MedDRA System Organ Class and Preferred Term</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr valign="top">
<th align="left" axis="1" rowspan="1" colspan="1">Adverse Events</th>
<th align="center" colspan="2" axis="1" rowspan="1">Cohort 1 (10 μmol Mn/kg)</th>
<th align="center" colspan="2" axis="1" rowspan="1">Cohort 2 (20 μmol Mn/kg)</th>
<th align="center" colspan="2" axis="1" rowspan="1">Total</th>
</tr></thead>
<tbody>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">MedDRA system organ class</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Preferred term</td>
<td align="center" rowspan="1" colspan="1">n (%)</td>
<td align="center" rowspan="1" colspan="1">E</td>
<td align="center" rowspan="1" colspan="1">n (%)</td>
<td align="center" rowspan="1" colspan="1">E</td>
<td align="center" rowspan="1" colspan="1">n (%)</td>
<td align="center" rowspan="1" colspan="1">E</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Total AEs</td>
<td align="center" rowspan="1" colspan="1">4 (67%)</td>
<td align="center" rowspan="1" colspan="1">9</td>
<td align="center" rowspan="1" colspan="1">8 (100%)</td>
<td align="center" rowspan="1" colspan="1">20</td>
<td align="center" rowspan="1" colspan="1">12 (86%)</td>
<td align="center" rowspan="1" colspan="1">29</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Vascular disorders</td>
<td align="center" rowspan="1" colspan="1">3 (50%)</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">2 (25%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">5 (36%)</td>
<td align="center" rowspan="1" colspan="1">7</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Flushing</td>
<td align="center" rowspan="1" colspan="1">2 (33%)</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">2 (25%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">4 (29%)</td>
<td align="center" rowspan="1" colspan="1">5</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Hematoma</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Hot flush</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">General disorders and administration site conditions</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">3 (38%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">4 (29%)</td>
<td align="center" rowspan="1" colspan="1">5</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Feeling hot</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">3 (38%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">3 (21%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Injection site erythema</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Injection site pain</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Investigations</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">4 (50%)</td>
<td align="center" rowspan="1" colspan="1">5</td>
<td align="center" rowspan="1" colspan="1">4 (29%)</td>
<td align="center" rowspan="1" colspan="1">5</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Alanine aminotransferase increased</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (13%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Aspartate aminotransferase increased</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (13%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Transaminases increased</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">3 (38%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">3 (21%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Gastrointestinal disorders</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">2 (25%)</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">3 (21%)</td>
<td align="center" rowspan="1" colspan="1">7</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Dry mouth</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Nausea</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">2 (25%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">2 (14%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Vomiting</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">2 (25%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">2 (14%)</td>
<td align="center" rowspan="1" colspan="1">3</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Infections and infestations</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1 (13%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">2 (14%)</td>
<td align="center" rowspan="1" colspan="1">2</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Lyme disease</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (13%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Nasopharyngitis</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Nervous system disorders</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">2 (25%)</td>
<td align="center" rowspan="1" colspan="1">2</td>
<td align="center" rowspan="1" colspan="1">2 (14%)</td>
<td align="center" rowspan="1" colspan="1">2</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Dysgeusia</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (13%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Headache</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (13%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Skin and subcutaneous tissue disorders</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Purpura</td>
<td align="center" rowspan="1" colspan="1">1 (17%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">0</td>
<td align="center" rowspan="1" colspan="1">1 (7.1%)</td>
<td align="center" rowspan="1" colspan="1">1</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p>AEs indicates adverse events; E, number of events; MedDRA, Medical Dictionary for Regulatory Authorities; n, number of participants.</p></div></div></section><p>The most commonly reported AEs were “Flushing/hot flush” (5 participants; n = 3 in cohort 1, n = 2 in cohort 2), “Feeling hot” (3 participants; n = 3 in cohort 2), increased transaminase levels (4 participants; n = 4 in cohort 2), and nausea/vomiting (2 participants; n = 2 in cohort 2).</p>
<p>There were no clinically relevant changes to baseline in clinical chemistry, hematology, urinalysis, or safety laboratory parameters over time, except for increased liver transaminases. The elevated transaminase levels, judged to be dose-dependent, were asymptomatic and not evident until 25 hours after the end of infusion. These elevations were transient, being assessed at the safety follow-up visit by the investigator as “Recovered/resolved.” All ECGs were interpreted as “Normal” or “Abnormal, not clinically significant” by the investigator at screening, predose, and all postdose assessments of the measurements.</p></section><section id="sec17"><h3 class="pmc_sec_title">Pharmacokinetics Analysis</h3>
<p>The PK parameters were calculated from a noncompartmental analysis using linear interpolation for increasing plasma levels and logarithmic interpolation for decreasing plasma levels (linear up-log-down method) over time. The peak Mn plasma concentrations over time occurred by the end of the 1-hour infusion and showed a C<sub>max</sub> of 0.9145 mg/L and 1.985 mg/L, for cohorts 1 and 2, respectively. After the end of infusion, the plasma concentration rapidly declined and was below LLOQ (0.1 mg/L) in most participants within 1 hour after the end of infusion (Fig. <a href="#F1" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="F1"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4db0/12316140/e8049917a85f/rli-60-577-g001.jpg" loading="lazy" height="385" width="706" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Linear-logarithmic (lin-log) plot of the geometric mean manganese plasma concentration versus time in cohort 1 (10 μmol Mn/kg, n = 6, data points expressed as circles and curve-fit as solid line) and cohort 2 (20 μmol Mn/kg, n = 8, data points expressed as squares and curve-fit as dashed line).</p></figcaption></figure><p>The mean AUC<sub>0-inf</sub> plasma exposure to pegfosimer manganese was approximately 2-fold as high in cohort 2 (1.913 h·mg/L), as compared with cohort 1 (1.008 h·mg/L). The mean initial half-life was approximately 7 minutes in both groups. The mean plasma CL was 0.5498 L/h/kg in cohort 1 and 0.6070 L/h/kg in cohort 2. Individual PK data are listed in Table <a href="#T4" class="usa-link">4</a>.</p>
<section class="tw xbox font-sm" id="T4"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Pharmacokinetics Parameters of Pegfosimer Manganese Plasma Mn-Levels</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr valign="top">
<th align="left" axis="1" rowspan="1" colspan="1">Parameter</th>
<th align="center" axis="1" rowspan="1" colspan="1">Cohort 1 (10 μmol Mn/kg)</th>
<th align="center" axis="1" rowspan="1" colspan="1">Cohort 2 (20 μmol Mn/kg)</th>
</tr></thead>
<tbody>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">T<sub>max</sub> (h)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">NC</td>
<td align="center" rowspan="1" colspan="1">NC</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">1.008 (1.00, 1.05)</td>
<td align="center" rowspan="1" colspan="1">1.000 (1.00, 1.02)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">C<sub>max</sub> (mg/L)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">0.9145 (0.1867)</td>
<td align="center" rowspan="1" colspan="1">1.985 (0.4522)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">0.9290 (0.681, 1.14)</td>
<td align="center" rowspan="1" colspan="1">1.925 (1.19, 2.52)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">T<sub>last</sub> (h)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">NC</td>
<td align="center" rowspan="1" colspan="1">NC</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">1.500 (1.25, 1.75)</td>
<td align="center" rowspan="1" colspan="1">1.750 (1.50, 2.67)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">AUC<sub>0-last</sub> (h·mg/L)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">0.8579 (0.1897)</td>
<td align="center" rowspan="1" colspan="1">1.821 (0.3838)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">0.9113 (0.616, 1.10)</td>
<td align="center" rowspan="1" colspan="1">1.897 (1.03, 2.40)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">AUC<sub>0-inf</sub> (h·mg/L)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">1.008 (0.1012)</td>
<td align="center" rowspan="1" colspan="1">1.913 (0.4192)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">0.9825 (0.916, 1.15)</td>
<td align="center" rowspan="1" colspan="1">1.984 (1.06, 2.57)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">Total CL (L/h/kg)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">0.5498 (0.05229)</td>
<td align="center" rowspan="1" colspan="1">0.6070 (0.1804)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">0.5599 (0.477, 0.602)</td>
<td align="center" rowspan="1" colspan="1">0.5525 (0.428, 1.03)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">V<sub>ss</sub> (L/kg)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">0.1501 (0.004450)</td>
<td align="center" rowspan="1" colspan="1">0.2148 (0.05921)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">0.1502 (0.145, 0.155)</td>
<td align="center" rowspan="1" colspan="1">0.2037 (0.137, 0.324)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">V<sub>z</sub> (L/kg)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">0.1651 (0.04279)</td>
<td align="center" rowspan="1" colspan="1">0.3635 (0.2076)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">0.1534 (0.128, 0.226)</td>
<td align="center" rowspan="1" colspan="1">0.2714 (0.221, 0.796)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">T<sub>½initial</sub> (min)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">6</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">7.171 (1.017)</td>
<td align="center" rowspan="1" colspan="1">6.879 (1.362)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">6.985 (5.90, 8.83)</td>
<td align="center" rowspan="1" colspan="1">6.865 (4.08, 8.43)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1">T<sub>½z</sub> (min)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> n</td>
<td align="center" rowspan="1" colspan="1">4</td>
<td align="center" rowspan="1" colspan="1">8</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
<td align="center" rowspan="1" colspan="1">12.78 (4.662)</td>
<td align="center" rowspan="1" colspan="1">27.54 (19.29)</td>
</tr>
<tr valign="top">
<td align="left" rowspan="1" colspan="1"> Median (min, max)</td>
<td align="center" rowspan="1" colspan="1">10.96 (9.51, 19.7)</td>
<td align="center" rowspan="1" colspan="1">17.95 (10.4, 61.9)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn4_pmc"><p>AUC<sub>0-inf</sub> indicates area under the plasma concentration-time curve from time 0 extrapolated to infinite time; AUC<sub>0-last</sub>, area under the plasma concentration-time curve from time 0 extrapolated to last measurable time; CL, total body clearance; C<sub>max</sub>, maximum plasma concentration; n, number of participants; NC, not calculated; SD, standard deviation; T<sub>last</sub>, time of last observed plasma concentration; T<sub>max</sub>, time to C<sub>max</sub>; T<sub>½</sub>, plasma elimination half-life; T<sub>1/2initial</sub>, initial elimination half-life; T<sub>1/2z</sub>, terminal plasma elimination half-life; V<sub>ss</sub>, volume of distribution at steady state; V<sub>z</sub>, volume of distribution associated with the terminal elimination phase.</p></div></div></section></section><section id="sec18"><h3 class="pmc_sec_title">Contrast Enhancement Evaluation</h3>
<p>Contrast enhancement efficacy was evaluated based on the SNR and CNR changes from the baseline precontrast MRI as well as the ability to produce images of clinical relevance. Individual changes of increased absolute CNR and SNR in the primary breast tumor could be observed in 11 out of 14 participants (Table <a href="#T5" class="usa-link">5</a>). Individual changes of increased absolute CNR and SNR in the liver and pancreas were also observed in all participants and cohorts (Supplementary Information S1, <a href="http://links.lww.com/RLI/B3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://links.lww.com/RLI/B3</a>). One participant in cohort 1 (1/6, 17%) and 1 participant in cohort 2 (1/8, 12.5%) did not obtain SNR and CNR calculations for the primary breast tumors, as the lesion was missed by the radiologist. One participant in cohort 2 (1/8, 12.5%, participant 9) did not complete the postcontrast scans due to discomfort. All participants (6/6, 100%) in cohort 1 were images with a 1.5 T field strength. In cohort 2, 2 participants (2/8, 25%) were imaged with a 1.5 T field strength, and 6 participants (6/8, 75%, remaining participants) were imaged with a field strength of 3 T. The reason for using 1.5 or 3 T field strength depended on which site the participants were recruited to.</p>
<section class="tw xbox font-sm" id="T5"><h4 class="obj_head">TABLE 5.</h4>
<div class="caption p"><p>Individual Mean Contrast-to-Noise Ratios and Signal-to-Noise Ratios From Participants in Cohort 1 (10 μmol Mn/kg) and Cohort 2 (20 μmol Mn/kg) in the Primary Breast Tumor at Baseline Precontrast MRI, 2 or 3 Hours MRI Poststart of Infusion, and 5 Hours MRI Poststart of Infusion With Pegfosimer Manganese</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr valign="top">
<th align="left" rowspan="2" axis="1" colspan="1">Cohort</th>
<th align="center" rowspan="2" axis="1" colspan="1">Participant</th>
<th align="center" rowspan="2" axis="1" colspan="1">Field (T)</th>
<th align="center" rowspan="2" axis="1" colspan="1">Metric</th>
<th align="center" colspan="3" axis="1" rowspan="1">Primary Breast Tumor</th>
</tr>
<tr valign="top">
<th align="center" axis="1" rowspan="1" colspan="1">Baseline MRI</th>
<th align="center" axis="1" rowspan="1" colspan="1">2 or 3 h MRI</th>
<th align="center" axis="1" rowspan="1" colspan="1">5 h MRI</th>
</tr>
</thead>
<tbody>
<tr valign="top">
<td align="left" rowspan="12" colspan="1">1</td>
<td align="center" rowspan="2" colspan="1">1</td>
<td align="center" rowspan="2" colspan="1">1.5</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">0.978</td>
<td align="center" rowspan="1" colspan="1">
<strong>1.420</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>1.439</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">5.635</td>
<td align="center" rowspan="1" colspan="1">
<strong>5.991</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>6.680</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">2</td>
<td align="center" rowspan="2" colspan="1">1.5</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">0.731</td>
<td align="center" rowspan="1" colspan="1">0.419</td>
<td align="center" rowspan="1" colspan="1">−0.899</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">3.420</td>
<td align="center" rowspan="1" colspan="1">2.988</td>
<td align="center" rowspan="1" colspan="1">2.289</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">3</td>
<td align="center" rowspan="2" colspan="1">1.5</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">2.176</td>
<td align="center" rowspan="1" colspan="1">
<strong>2.643</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>2.469</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">7.604</td>
<td align="center" rowspan="1" colspan="1">
<strong>8.058</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>7.872</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">4</td>
<td align="center" rowspan="2" colspan="1">1.5</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">1.074</td>
<td align="center" rowspan="1" colspan="1">
<strong>2.649</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>2.373</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">5.500</td>
<td align="center" rowspan="1" colspan="1">
<strong>5.803</strong>
</td>
<td align="center" rowspan="1" colspan="1">4.662</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">5</td>
<td align="center" rowspan="2" colspan="1">1.5</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">6</td>
<td align="center" rowspan="2" colspan="1">1.5</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">2.998</td>
<td align="center" rowspan="1" colspan="1">2.676</td>
<td align="center" rowspan="1" colspan="1">
<strong>3.021</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">9.185</td>
<td align="center" rowspan="1" colspan="1">
<strong>9.316</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>9.500</strong>
</td>
</tr>
<tr valign="top">
<td align="left" rowspan="16" colspan="1">2</td>
<td align="center" rowspan="2" colspan="1">7</td>
<td align="center" rowspan="2" colspan="1">1.5</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">1.338</td>
<td align="center" rowspan="1" colspan="1">
<strong>1.808</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>1.531</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">6.439</td>
<td align="center" rowspan="1" colspan="1">
<strong>6.624</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>6.531</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">8</td>
<td align="center" rowspan="2" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">0.044</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.163</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.178</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">0.295</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.490</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.520</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">9</td>
<td align="center" rowspan="2" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">10</td>
<td align="center" rowspan="2" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">0.263</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.463</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.402</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">0.737</td>
<td align="center" rowspan="1" colspan="1">
<strong>1.066</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>1.032</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">11</td>
<td align="center" rowspan="2" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">0.166</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.368</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.364</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">0.605</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.916</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.984</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">12</td>
<td align="center" rowspan="2" colspan="1">1.5</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">−0.041</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.876</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>1.314</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">3.162</td>
<td align="center" rowspan="1" colspan="1">
<strong>4.328</strong>
</td>
<td align="center" rowspan="1" colspan="1">
<strong>4.699</strong>
</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">13</td>
<td align="center" rowspan="2" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
<td align="center" rowspan="1" colspan="1">NE</td>
</tr>
<tr valign="top">
<td align="center" rowspan="2" colspan="1">14</td>
<td align="center" rowspan="2" colspan="1">3</td>
<td align="center" rowspan="1" colspan="1">CNR</td>
<td align="center" rowspan="1" colspan="1">0.074</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.082</strong>
</td>
<td align="center" rowspan="1" colspan="1">0.031</td>
</tr>
<tr valign="top">
<td align="center" rowspan="1" colspan="1">SNR</td>
<td align="center" rowspan="1" colspan="1">0.417</td>
<td align="center" rowspan="1" colspan="1">
<strong>0.432</strong>
</td>
<td align="center" rowspan="1" colspan="1">0.384</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn5_pmc">
<p>Bolded values denote positive changes from baseline MRI.</p>
<p>NE indicates not evaluated.</p>
</div></div></section><p>Pegfosimer manganese was subjectively evaluated for its ability to produce clinically relevant low-background MRI scans for clinical visualization of primary breast tumor (Fig. <a href="#F2" class="usa-link">2</a>), liver, and pancreas (Fig. <a href="#F3" class="usa-link">3</a>), as well as quantification of the SNR and CNR in ROIs. At the dose level of 20 μmol Mn/kg, the iSRC judged to expand the cohort to assess the efficacy of the study drug.</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4db0/12316140/dfeea9add08d/rli-60-577-g002.jpg" loading="lazy" height="937" width="706" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Four representative T1-weighted MOLLI 3 T (A–C) and 1.5 T (D) MRI scan series of primary breast cancer tumor (arrows) baseline precontrast MRI (left column), 2 to 3 hours postdosing (post-dose 1, center column), and 5 hours postdosing (postdose 2, right column) after the start of the 1-hour infusion with 20 μmol Mn/kg pegfosimer manganese. The noise was individually windowed for background and graded contrast.</p></figcaption></figure><figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4db0/12316140/738d67b767eb/rli-60-577-g003.jpg" loading="lazy" height="229" width="706" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Representative abdominal MRI T1-weighted 3 T scans before (left), 3 hours after (center), and 5 hours after (right) the 1-hour infusion of 20 μmol Mn/kg pegfosimer manganese.</p></figcaption></figure></section></section><section id="sec19"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>The study was an FIH, open-label, phase 1 trial designed as a single intravenous infusion, dose-escalation study of the safety and tolerability of pegfosimer manganese, a novel macromolecular Mn-based contrast agent. Additionally, PKs and preliminary MRI contrast enhancement were explored.</p>
<p>While several tumor types were feasible in the FIH study, based on the proposed passive targeting mechanism for pegfosimer manganese, the study objectives were first explored in participants with breast cancer. Once a pegfosimer manganese dose level that was safe and sufficient for MRI had been established, a separate pancreatic cancer patient expansion arm was included. However, no pancreatic cancer patients were included in the study. Pegfosimer manganese was tolerated at the dosage of 20 μmol Mn/kg, and given the predefined dose escalation stopping rule, no further dose escalation was made from this point, and the cohort was expanded to n = 8. Therefore, this dose level should not be considered as a maximum tolerated dose.</p>
<p>Pegfosimer manganese was generally considered safe and well-tolerated by the participants in the study. There were no deaths, SAEs, or AEs leading to withdrawal of a participant from the study. Participants in the higher dose group tended to report more AEs. The most common AEs were flushing/hot flush, feeling hot, transaminases increased, and nausea/vomiting. Nausea and vomiting have commonly been reported as AEs in other studies with Mn-based contrast agents.<a href="#bib20" class="usa-link" aria-describedby="bib20">20</a> The investigator judged pegfosimer manganese to be emetic, suggesting that a prophylactic antiemetic treatment in further studies could benefit the patients. A further study has since been completed in a different population of younger females suffering from endometriosis (<a href="https://clinicaltrials.gov/ct2/show/NCT05664828" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05664828</a>), including coadministration of the antispasmodic, Buscopan, a standard clinical practice at the site for pelvic imaging.</p>
<p>A transient nonclinically significant elevation in plasma transaminase levels was also observed in 2 participants. This elevation is suggestive that these adverse effects are likely related to a release of manganese ions from the nanoparticles, a profile similar to other manganese-based contrast agents.<a href="#bib21" class="usa-link" aria-describedby="bib21">21</a>
</p>
<p>The independent radiologist judged the pegfosimer manganese-mediated MRI contrast enhancement to be of clinical relevance to visualizing malignant breast tumors. The second post-MRI time point shows sufficient contrast enhancement in the tumor for at least 4 hours postend of infusion; this will allow for extensive MRI scanning, and high-resolution protocols should they be indicated. A contrast enhancement in the liver and pancreas is common for manganese-based contrast agents.<a href="#bib22" class="usa-link" aria-describedby="bib22">22</a> Pegfosimer manganese showed this enhancement of the liver and pancreas, with clear delineation of several anatomical details such as the pancreatic ducts. A deeper understanding of the clinical application of pegfosimer manganese in enhancing the liver, and pancreas will require further consideration.</p>
<p>As the proposed EPR mechanism of action is not unique to breast tumors, and given the level of contrast enhancement shown in the study, this may indicate broader applicability in the diagnosis and characterization of other solid tumor types.<a href="#bib23" class="usa-link" aria-describedby="bib23">23</a>,<a href="#bib24" class="usa-link" aria-describedby="bib24">24</a> This would need to be strengthened by performing larger, statistically powered clinical studies in the future. Additional studies may also include imaging of lymph nodes, where the mechanism of action is compatible with enhancement of metastases. Moreover, there may be potential for the product to be used for early detection and monitoring of tumor response to therapy. Additionally, there may also be further potential for using pegfosimer manganese as a screening tool to predict the prospects of success for other drugs relying on the EPR effect.</p>
<p>As a phase 1 study, the primary objective was to ensure safety. Although Mn-based contrast agents have previously been successfully used for MRI, exposure to excess Mn could be a safety risk. Careful blood-sampling and elementary analysis for Mn was therefore incorporated in the current study to allow PK-modeling in support of any safety observations that could potentially be attributed to Mn. The present study applied the Linear-up/Logarithmic-down model to analyze plasma Mn PK, aligning with International Conference on Harmonization/GCP Guidelines for Statistics in Clinical Trials. The model accounts for the infusion phase (linear trapezoidal method for increasing concentrations) and clearance phase (logarithmic calculation for blood clearance). However, this approach may not optimally model pegfosimer manganese due to nanoparticle-related factors such as particle size distribution, and renal clearance thus may lead to inaccuracies in AUC calculations.</p>
<p>The model specified in the clinical study protocol was chosen based on best assumptions for support of any safety signal potentially attributed to Mn at the time of study start. It does not however comprehensively describe PK for the polymeric carrier particles of pegfosimer manganese. This was explored in a later, separate exploratory study<a href="#bib25" class="usa-link" aria-describedby="bib25">25</a> published before completion of this manuscript. This subsequent, exploratory study, using the surrogate analyte Si in the same blood samples, developed in-house/non-GxP, nontraditional PK model to address these challenges. Unlike the Lin-up/Log-down analysis showing a 7-minute initial half-life for plasma Mn, the custom model suggested a 42-minute half-life for Si, reflecting the postrenal filtrated portion of pegfosimer manganese rather than maximum blood Mn concentration.</p>
<p>While the results from Mn and Si analyses are not directly comparable due to the different models, the results are indicative of Mn-ion dissociation from the carrier particles. In the paper by Axelsson et al, it was considered that this is mainly due to competitive binding to albumin. The clinical results shown here suggest that this process is not instantaneous and that there is sufficient association for delivery to the tumors through the remaining manganese-carrying particles leading to clinically relevant tumor contrast with minimal background enhancement. Future steps include applying the custom model to the plasma Mn-data, which would account for nanoparticle-specific behavior, to be able to correlate Mn with Si to address potential Mn-dissociation post-infusion. There were several limitations to the study. First, the subjective classification of whether an image was of diagnostic quality, as judged by a single radiologist. Applying central imaging training before the inclusion of image reading and agreement by several experienced individuals would be of value in follow-up studies to reduce radiologist reader bias. The study had few participants to conclude the proof of concept of the contrast enhancement. All individuals were White, and future studies should look to include a more diverse population. In addition, other solid tumor types should be investigated to understand the proof of concept and pegfosimer manganese's wider applicability. Lastly, further studies need to build on the small sample size in this study with larger, statistically powered investigations.</p>
<p>Overall, the results of this study indicate that pegfosimer manganese has an acceptable safety profile providing sufficient contrast enhancement at a clinically relevant dose for assessment of appropriate MRI sequences in participants with primary breast tumors.</p>
<p>Further investigation is warranted to fully explore the potential of pegfosimer manganese and its ability to meet the rising need for improved tumor characterization, diagnosis, and follow-up.</p></section><section id="sec20"><h2 class="pmc_sec_title">Supplementary Material</h2>
<figure class="fig xbox font-sm" id="s001"><div class="media p"><div class="caption">
<a href="/articles/instance/12316140/bin/rli-60-577-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">rli-60-577-s001.docx</a><sup> (19.5KB, docx) </sup>
</div></div>
<div class="p text-right font-secondary"><a href="figure/s001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGMENTS</h2>
<p>We thank Edvin Johansson for designing the imaging sequences and image quantification. We thank Dr Folke Sjöberg for contributing to the independent safety review committee. We thank Shahin Abdsaleh for contributing to image analysis. We thank Tove Sivik and Liliya Shcherbina for study initiation, project management, and study oversight.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn2"><p>Conflicts of interest and sources of funding: This work was funded by Spago Nanomedical AB, Lund, Sweden.</p></div>
<div class="fn p" id="fn4"><p>Competing interests: F.W., D.C., and A.K. have no competing interests. O.A., P.H., and M.H. are shareholders and O.A., P.H., S.L., and M.H. are employees of Spago Nanomedical AB.</p></div>
<div class="fn p" id="fn5"><p>Supplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’s website, <a href="http://www.investigativeradiology.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.investigativeradiology.com</a>.</p></div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bib1">
<span class="label">1.</span><cite>
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.
</cite> [<a href="https://doi.org/10.3322/caac.21763" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36633525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CA%20Cancer%20J%20Clin&amp;title=Cancer%20statistics,%202023&amp;author=RL%20Siegel&amp;author=KD%20Miller&amp;author=NS%20Wagle&amp;volume=73&amp;publication_year=2023&amp;pages=17-48&amp;pmid=36633525&amp;doi=10.3322/caac.21763&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib2">
<span class="label">2.</span><cite>
Lehman CD Wellman RD Buist DS et al. , Breast Cancer Surveillance Consortium . Diagnostic accuracy of digital screening mammography with and without computer-aided detection. JAMA Intern Med. 2015;175:1828–1837.
</cite> [<a href="https://doi.org/10.1001/jamainternmed.2015.5231" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4836172/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26414882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Intern%20Med&amp;title=Diagnostic%20accuracy%20of%20digital%20screening%20mammography%20with%20and%20without%20computer-aided%20detection&amp;author=CD%20Lehman&amp;author=RD%20Wellman&amp;author=DS%20Buist&amp;volume=175&amp;publication_year=2015&amp;pages=1828-1837&amp;pmid=26414882&amp;doi=10.1001/jamainternmed.2015.5231&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib3">
<span class="label">3.</span><cite>
Brown AL, Vijapura C, Patel M, et al. Breast cancer in dense breasts: detection challenges and supplemental screening opportunities. Radiographics. 2023;43:e230024.
</cite> [<a href="https://doi.org/10.1148/rg.230024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37792590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiographics&amp;title=Breast%20cancer%20in%20dense%20breasts:%20detection%20challenges%20and%20supplemental%20screening%20opportunities&amp;author=AL%20Brown&amp;author=C%20Vijapura&amp;author=M%20Patel&amp;volume=43&amp;publication_year=2023&amp;pages=e230024&amp;pmid=37792590&amp;doi=10.1148/rg.230024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib4">
<span class="label">4.</span><cite>
Plana MN, Carreira C, Muriel A, et al. Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol. 2012;22:26–38.
</cite> [<a href="https://doi.org/10.1007/s00330-011-2238-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21847541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Radiol&amp;title=Magnetic%20resonance%20imaging%20in%20the%20preoperative%20assessment%20of%20patients%20with%20primary%20breast%20cancer:%20systematic%20review%20of%20diagnostic%20accuracy%20and%20meta-analysis&amp;author=MN%20Plana&amp;author=C%20Carreira&amp;author=A%20Muriel&amp;volume=22&amp;publication_year=2012&amp;pages=26-38&amp;pmid=21847541&amp;doi=10.1007/s00330-011-2238-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib5">
<span class="label">5.</span><cite>
Little RA, Barjat H, Hare JI, et al. Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: how do permeability and perfusion vary between human tumours?
Magn Reson Imaging. 2018;46:98–105.
</cite> [<a href="https://doi.org/10.1016/j.mri.2017.11.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29154898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Magn%20Reson%20Imaging&amp;title=Evaluation%20of%20dynamic%20contrast-enhanced%20MRI%20biomarkers%20for%20stratified%20cancer%20medicine:%20how%20do%20permeability%20and%20perfusion%20vary%20between%20human%20tumours?&amp;author=RA%20Little&amp;author=H%20Barjat&amp;author=JI%20Hare&amp;volume=46&amp;publication_year=2018&amp;pages=98-105&amp;pmid=29154898&amp;doi=10.1016/j.mri.2017.11.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib6">
<span class="label">6.</span><cite>
Caravan P. Divalent manganese complexes as potential replacements for gadolinium-based contrast agents. Invest Radiol. 2024;59:187–196.
</cite> [<a href="https://doi.org/10.1097/RLI.0000000000001053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10841418/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38038701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Invest%20Radiol&amp;title=Divalent%20manganese%20complexes%20as%20potential%20replacements%20for%20gadolinium-based%20contrast%20agents&amp;author=P%20Caravan&amp;volume=59&amp;publication_year=2024&amp;pages=187-196&amp;pmid=38038701&amp;doi=10.1097/RLI.0000000000001053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib7">
<span class="label">7.</span><cite>
van Nijnatten TJA, Morscheid S, Baltzer PAT, et al. Contrast-enhanced breast imaging: current status and future challenges. Eur J Radiol. 2024;171:111312.
</cite> [<a href="https://doi.org/10.1016/j.ejrad.2024.111312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38237520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Radiol&amp;title=Contrast-enhanced%20breast%20imaging:%20current%20status%20and%20future%20challenges&amp;author=TJA%20van%20Nijnatten&amp;author=S%20Morscheid&amp;author=PAT%20Baltzer&amp;volume=171&amp;publication_year=2024&amp;pages=111312&amp;pmid=38237520&amp;doi=10.1016/j.ejrad.2024.111312&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib8">
<span class="label">8.</span><cite>
De Bienassis K, Slawomirski L, Kelly D, et al. The economics of diagnostic safety. In: OECD Policy brief September 2024. Paris, France: OECD Publishing; 2024.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=OECD%20Policy%20brief%20September%202024&amp;author=K%20De%20Bienassis&amp;author=L%20Slawomirski&amp;author=D%20Kelly&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib9">
<span class="label">9.</span><cite>
Zhu D, Liu F, Ma L, et al. Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents. Int J Mol Sci. 2013;14:10591–10607.
</cite> [<a href="https://doi.org/10.3390/ijms140510591" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3676856/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23698781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Mol%20Sci&amp;title=Nanoparticle-based%20systems%20for%20T(1)-weighted%20magnetic%20resonance%20imaging%20contrast%20agents&amp;author=D%20Zhu&amp;author=F%20Liu&amp;author=L%20Ma&amp;volume=14&amp;publication_year=2013&amp;pages=10591-10607&amp;pmid=23698781&amp;doi=10.3390/ijms140510591&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib10">
<span class="label">10.</span><cite>
Islam W, Niidome T, Sawa T. Enhanced permeability and retention effect as a ubiquitous and epoch-making phenomenon for the selective drug targeting of solid tumors. J Pers Med. 2022;12:1964.
</cite> [<a href="https://doi.org/10.3390/jpm12121964" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9784116/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36556185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pers%20Med&amp;title=Enhanced%20permeability%20and%20retention%20effect%20as%20a%20ubiquitous%20and%20epoch-making%20phenomenon%20for%20the%20selective%20drug%20targeting%20of%20solid%20tumors&amp;author=W%20Islam&amp;author=T%20Niidome&amp;author=T%20Sawa&amp;volume=12&amp;publication_year=2022&amp;pages=1964&amp;pmid=36556185&amp;doi=10.3390/jpm12121964&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib11">
<span class="label">11.</span><cite>
Ikeda-Imafuku M, Wang LL, Rodrigues D, et al. Strategies to improve the EPR effect: a mechanistic perspective and clinical translation. J Control Release. 2022;345:512–536.
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2022.03.043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35337939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Control%20Release&amp;title=Strategies%20to%20improve%20the%20EPR%20effect:%20a%20mechanistic%20perspective%20and%20clinical%20translation&amp;author=M%20Ikeda-Imafuku&amp;author=LL%20Wang&amp;author=D%20Rodrigues&amp;volume=345&amp;publication_year=2022&amp;pages=512-536&amp;pmid=35337939&amp;doi=10.1016/j.jconrel.2022.03.043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib12">
<span class="label">12.</span><cite>
Henoumont C, Devreux M, Laurent S. Mn-based MRI contrast agents: an overview. Molecules. 2023;28:7275.
</cite> [<a href="https://doi.org/10.3390/molecules28217275" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10648041/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37959694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Mn-based%20MRI%20contrast%20agents:%20an%20overview&amp;author=C%20Henoumont&amp;author=M%20Devreux&amp;author=S%20Laurent&amp;volume=28&amp;publication_year=2023&amp;pages=7275&amp;pmid=37959694&amp;doi=10.3390/molecules28217275&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib13">
<span class="label">13.</span><cite>
World Medical Association . World medical association declaration of Helsinki: ethical principles for medical research involving human participants. JAMA. 2024;333:71–74.</cite> [<a href="https://doi.org/10.1001/jama.2024.21972" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39425955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=World%20medical%20association%20declaration%20of%20Helsinki:%20ethical%20principles%20for%20medical%20research%20involving%20human%20participants&amp;volume=333&amp;publication_year=2024&amp;pages=71-74&amp;pmid=39425955&amp;doi=10.1001/jama.2024.21972&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib14">
<span class="label">14.</span><cite>
Azam F, Latif MF, Farooq A, et al. Performance status assessment by using ECOG (eastern cooperative oncology group) score for cancer patients by oncology healthcare professionals. Case Rep Oncol. 2019;12:728–736.
</cite> [<a href="https://doi.org/10.1159/000503095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6792426/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31616281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Case%20Rep%20Oncol&amp;title=Performance%20status%20assessment%20by%20using%20ECOG%20(eastern%20cooperative%20oncology%20group)%20score%20for%20cancer%20patients%20by%20oncology%20healthcare%20professionals&amp;author=F%20Azam&amp;author=MF%20Latif&amp;author=A%20Farooq&amp;volume=12&amp;publication_year=2019&amp;pages=728-736&amp;pmid=31616281&amp;doi=10.1159/000503095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib15">
<span class="label">15.</span><cite>
National Cancer Institute Cancer therapy evaluation program. Common terminology criteria for adverse events, CTCAE
v5.0. 2018.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=CTCAE&amp;title=National%20Cancer%20Institute%20Cancer%20therapy%20evaluation%20program.%20Common%20terminology%20criteria%20for%20adverse%20events&amp;volume=v5.0&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib16">
<span class="label">16.</span><cite>
Sibille M, Patat A, Caplain H, et al. A safety grading scale to support dose escalation and define stopping rules for healthy subject first-entry-into-man studies: some points to consider from the French Club phase I working group. Br J Clin Pharmacol. 2010;70:736–748.
</cite> [<a href="https://doi.org/10.1111/j.1365-2125.2010.03741.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2997314/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21039768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Clin%20Pharmacol&amp;title=A%20safety%20grading%20scale%20to%20support%20dose%20escalation%20and%20define%20stopping%20rules%20for%20healthy%20subject%20first-entry-into-man%20studies:%20some%20points%20to%20consider%20from%20the%20French%20Club%20phase%20I%20working%20group&amp;author=M%20Sibille&amp;author=A%20Patat&amp;author=H%20Caplain&amp;volume=70&amp;publication_year=2010&amp;pages=736-748&amp;pmid=21039768&amp;doi=10.1111/j.1365-2125.2010.03741.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib17">
<span class="label">17.</span><cite>
WHO recommendations for grading of acute and subacute toxicity: reporting the results of cancer treatment. Cancer. 1981;47:207–214.7459811
</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=WHO%20recommendations%20for%20grading%20of%20acute%20and%20subacute%20toxicity:%20reporting%20the%20results%20of%20cancer%20treatment&amp;volume=47&amp;publication_year=1981&amp;pages=207-214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib18">
<span class="label">18.</span><cite>
NIH . Division of AIDS table for grading the severity of adult and paediatric adverse events. 2004.</cite>
</li>
<li id="bib19">
<span class="label">19.</span><cite>
FDA . Guidance for industry: Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. 2007.</cite> [<a href="https://doi.org/10.1016/j.vaccine.2023.07.072" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37532612/" class="usa-link">PubMed</a>]</li>
<li id="bib20">
<span class="label">20.</span><cite>
Brismar TB, Geisel D, Kartalis N, et al. Oral manganese chloride Tetrahydrate: a novel magnetic resonance liver imaging agent for patients with renal impairment: efficacy, safety, and clinical implication. Invest Radiol. 2024;59:197–205.
</cite> [<a href="https://doi.org/10.1097/RLI.0000000000001042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11441735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37934630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Invest%20Radiol&amp;title=Oral%20manganese%20chloride%20Tetrahydrate:%20a%20novel%20magnetic%20resonance%20liver%20imaging%20agent%20for%20patients%20with%20renal%20impairment:%20efficacy,%20safety,%20and%20clinical%20implication&amp;author=TB%20Brismar&amp;author=D%20Geisel&amp;author=N%20Kartalis&amp;volume=59&amp;publication_year=2024&amp;pages=197-205&amp;pmid=37934630&amp;doi=10.1097/RLI.0000000000001042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib21">
<span class="label">21.</span><cite>
Federle MP, Chezmar JL, Rubin DL, et al. Safety and Efficacy of Mangafodipir Trisodium (MnDPDP) Injection for Hepatic MRI in Adults: Results of the U.S. Multicenter Phase III Clinical Trials (Safety). J Magn Reson Imaging. 2000;12:186–197.
</cite> [<a href="https://doi.org/10.1002/1522-2586(200007)12:1&lt;186::aid-jmri21&gt;3.0.co;2-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10931579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Magn%20Reson%20Imaging&amp;title=Safety%20and%20Efficacy%20of%20Mangafodipir%20Trisodium%20(MnDPDP)%20Injection%20for%20Hepatic%20MRI%20in%20Adults:%20Results%20of%20the%20U.S.%20Multicenter%20Phase%20III%20Clinical%20Trials%20(Safety)&amp;author=MP%20Federle&amp;author=JL%20Chezmar&amp;author=DL%20Rubin&amp;volume=12&amp;publication_year=2000&amp;pages=186-197&amp;pmid=10931579&amp;doi=10.1002/1522-2586(200007)12:1&lt;186::aid-jmri21&gt;3.0.co;2-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib22">
<span class="label">22.</span><cite>
Wang J, Wang H, Ramsay IA, et al. Manganese-based contrast agents for magnetic resonance imaging of liver tumors: structure-activity relationships and lead candidate evaluation. J Med Chem. 2018;61:8811–8824.
</cite> [<a href="https://doi.org/10.1021/acs.jmedchem.8b00964" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6442678/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30204438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Chem&amp;title=Manganese-based%20contrast%20agents%20for%20magnetic%20resonance%20imaging%20of%20liver%20tumors:%20structure-activity%20relationships%20and%20lead%20candidate%20evaluation&amp;author=J%20Wang&amp;author=H%20Wang&amp;author=IA%20Ramsay&amp;volume=61&amp;publication_year=2018&amp;pages=8811-8824&amp;pmid=30204438&amp;doi=10.1021/acs.jmedchem.8b00964&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib23">
<span class="label">23.</span><cite>
Sharifi M, Cho WC, Ansariesfahani A, et al. An updated review on EPR-based solid tumor targeting nanocarriers for cancer treatment. Cancer. 2022;14:2868.</cite> [<a href="https://doi.org/10.3390/cancers14122868" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9220781/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35740534/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=An%20updated%20review%20on%20EPR-based%20solid%20tumor%20targeting%20nanocarriers%20for%20cancer%20treatment&amp;author=M%20Sharifi&amp;author=WC%20Cho&amp;author=A%20Ansariesfahani&amp;volume=14&amp;publication_year=2022&amp;pages=2868&amp;pmid=35740534&amp;doi=10.3390/cancers14122868&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib24">
<span class="label">24.</span><cite>
Subhan MA, Yalamarty SSK, Filipczak N, et al. Recent advances in tumor targeting via EPR effect for cancer treatment. J Pers Med. 2021;11:571.
</cite> [<a href="https://doi.org/10.3390/jpm11060571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8234032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34207137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Pers%20Med&amp;title=Recent%20advances%20in%20tumor%20targeting%20via%20EPR%20effect%20for%20cancer%20treatment&amp;author=MA%20Subhan&amp;author=SSK%20Yalamarty&amp;author=N%20Filipczak&amp;volume=11&amp;publication_year=2021&amp;pages=571&amp;pmid=34207137&amp;doi=10.3390/jpm11060571&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib25">
<span class="label">25.</span><cite>
Axelsson O, Yousefpour N, Björnberg O, et al. Size-dependent renal filtration model explains human pharmacokinetics of a functional nanoparticle: the SPAGOPIX-01 clinical trial. Nanomedicine. 2024;62:102774.
</cite> [<a href="https://doi.org/10.1016/j.nano.2024.102774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39029886/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanomedicine&amp;title=Size-dependent%20renal%20filtration%20model%20explains%20human%20pharmacokinetics%20of%20a%20functional%20nanoparticle:%20the%20SPAGOPIX-01%20clinical%20trial&amp;author=O%20Axelsson&amp;author=N%20Yousefpour&amp;author=O%20Bj%C3%B6rnberg&amp;volume=62&amp;publication_year=2024&amp;pages=102774&amp;pmid=39029886&amp;doi=10.1016/j.nano.2024.102774&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Investigative Radiology are provided here courtesy of <strong>Wolters Kluwer Health</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1097/RLI.0000000000001164"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/rli-60-577.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (399.9 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12316140/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12316140/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12316140%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12316140/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12316140/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12316140/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/39946211/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12316140/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/39946211/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12316140/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12316140/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="AwASAZ8iceihTDDjodshQBZTiOSJzUEua6RYcxmdCbjQXF1ELIkEHfjj8k2rsW8j">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
